Actuate Therapeutics Files 8-K on Security Holder Vote
Ticker: ACTU · Form: 8-K · Filed: May 23, 2025 · CIK: 1652935
| Field | Detail |
|---|---|
| Company | Actuate Therapeutics, Inc. (ACTU) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Actuate Therapeutics had a security holder vote on 5/22/25, details in new 8-K.
AI Summary
Actuate Therapeutics, Inc. filed an 8-K on May 23, 2025, reporting on a matter submitted to a vote of its security holders on May 22, 2025. The company, formerly known as Apotheca Therapeutics, Inc., is incorporated in Delaware and headquartered in Fort Worth, Texas.
Why It Matters
This filing indicates a significant event where security holders are voting on a specific matter, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a security holder vote without immediate financial implications detailed.
Key Players & Entities
- Actuate Therapeutics, Inc. (company) — Registrant
- Apotheca Therapeutics, Inc. (company) — Former company name
- May 22, 2025 (date) — Date of earliest event reported
- May 23, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Fort Worth, Texas (location) — Principal executive offices
FAQ
What specific matter was submitted to a vote of Actuate Therapeutics' security holders?
The filing does not specify the exact matter submitted to a vote, only that it occurred on May 22, 2025.
When was Actuate Therapeutics, Inc. formerly known as?
Actuate Therapeutics, Inc. was formerly known as Apotheca Therapeutics, Inc.
In which state is Actuate Therapeutics, Inc. incorporated?
Actuate Therapeutics, Inc. is incorporated in Delaware.
What is the principal executive office address for Actuate Therapeutics, Inc.?
The principal executive office is located at 1751 River Run, Suite 400, Fort Worth, Texas 76107.
What is the filing date of this 8-K report?
This 8-K report was filed on May 23, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding ACTUATE THERAPEUTICS, INC. (ACTU).